Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome.
Irritable bowel syndrome (IBS) is one of the most common conditions encountered in clinical practice but one of the least well understood. Symptoms of this disorder are chronic, sometimes severe and often respond poorly to treatment, resulting in reduced quality of life. There is no specific test for IBS, although diagnostic tests may be performed to rule out other problems. In present clinical trial 51 patients of IBS were registered out of which 46 patients completed the treatment. Bilvadileha was administered for the duration of 12 weeks. The therapy showed statistically significant improvement in all the clinical features of IBS as well as in the IBS severity score.
Assistant Professor, Department of Roga Nidan and Vikrit Vijnana, Dhanwantari Ayurvedic Medical College, Mathura, Uttar Pradesh, India.
Ramanand
R
Tiwari
Assistant Professor, Department of Roga Nidan and Vikriti Vijnana, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Darshana H
DH
Pandya
Professor and Head, Department of Roga Nidan and Vikriti Vijnana, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Madhav Singh
MS
Baghel
Ayurvedic management; Bilvadileha; irritable bowel syndrome